Sign inJoin waitlistJoin the waitlist

Robert Mentz

Chief, Heart Failure Section · Duke University Hospital

Credentials: · · · · · · ·

History

Heart Failure Section · Duke University Hospital
Present
Duke University
2023–Present
Duke Clinical Research Institute
2014–Present

Duke University Hospital
2013–2014
Duke Clinical Research Institute
2013–2014
Advanced Heart Failure and Transplant Cardiology
Duke University Hospital
2012–2013
Cardiovascular Disease
Duke University Hospital
2010–2012
Internal Medicine
Duke University Hospital
2007–2010
Internal Medicine
Brigham and Women's Hospital
2007–2010
Emory University School of Medicine
2003–2007

Research

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine · 2017 · 1,649 citations
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Nature Medicine · 2022 · 758 citations
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent…
Review · Circulation · 2019 · 496 citations

Christopher O'Connor
141 papers
Adrian Hernandez
137 papers
Javed Butler
133 papers
Stephen Greene
112 papers
Anuradha Lala-Trindade
77 papers
Marat Fudim
74 papers
Adam DeVore
66 papers
GF
Gregg Fonarow
62 papers
Andrew Ambrosy
59 papers · 38 as a resident
Gary Felker
57 papers
David Whellan
52 papers
Ambarish Pandey
42 papers · 4 as a fellow

Grants

Research Triangle Center of Excellence in Regulatory Science and Innovation
Food and Drug Administration · U01
PI · $11.9M · Univ of North Carolina Chapel Hill
2023–2028
Transform-Hf Ccc
National Heart, Lung, and Blood Institute · U01
PI · $6.1M · Yale University
2018–2024

Clinical trials

PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health
Principal investigator · Completed
Duke University
2021–2022
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
Principal investigator · Completed · Phase 3
Duke University
2018–2022
Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)
Principal investigator · Completed · Phase 4
Duke University
2016–2018
Alleviant ALLAY-HFrEF Study
Site PI · Recruiting
Alleviant Medical, Inc.
2025–2028

Honors

FHFSA

medschool.duke.edu